BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31293046)

  • 41. Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer.
    Lee KM; Jung D; Hwang H; Son KL; Kim TY; Im SA; Lee KH; Hahm BJ
    J Psychosom Res; 2018 May; 108():14-19. PubMed ID: 29602320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients.
    Mahfouz FM; Park SB; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; King T; Goldstein D; Mizrahi D
    Clin Auton Res; 2022 Dec; 32(6):497-506. PubMed ID: 36129622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data.
    Smith EML; Zanville N; Kanzawa-Lee G; Donohoe C; Bridges C; Loprinzi C; Le-Rademacher J; Yang JJ
    Support Care Cancer; 2019 Jul; 27(7):2599-2608. PubMed ID: 30460399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.
    Kleckner IR; Jusko TA; Culakova E; Chung K; Kleckner AS; Asare M; Inglis JE; Loh KP; Peppone LJ; Miller J; Melnik M; Kasbari S; Ossip D; Mustian KM
    Breast Cancer Res Treat; 2021 Sep; 189(2):521-532. PubMed ID: 34191201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy.
    Vollmers PL; Mundhenke C; Maass N; Bauerschlag D; Kratzenstein S; Röcken C; Schmidt T
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1785-1792. PubMed ID: 29943097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes.
    Trendowski MR; Lusk CM; Ruterbusch JJ; Seaton R; Simon MS; Greenwald MK; Harper FWK; Beebe-Dimmer JL; Schwartz AG
    Cancer Med; 2021 Nov; 10(22):8151-8161. PubMed ID: 34687150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry.
    Thong MS; Mols F; Wang XS; Lemmens VE; Smilde TJ; van de Poll-Franse LV
    Eur J Cancer; 2013 May; 49(8):1957-66. PubMed ID: 23453750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
    Selvy M; Kerckhove N; Pereira B; Barreau F; Nguyen D; Busserolles J; Giraudet F; Cabrespine A; Chaleteix C; Soubrier M; Bay JO; Lemal R; Balayssac D
    Front Pharmacol; 2021; 12():637593. PubMed ID: 33967771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Living with chemotherapy-induced peripheral neuropathy: Uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors.
    Chan CW; Cheng H; Au SK; Leung KT; Li YC; Wong KH; Molassiotis A
    Eur J Oncol Nurs; 2018 Oct; 36():135-141. PubMed ID: 30322504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
    Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
    J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy.
    Cox-Martin E; Trahan LH; Cox MG; Dougherty PM; Lai EA; Novy DM
    Support Care Cancer; 2017 Jun; 25(6):1873-1879. PubMed ID: 28124735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry.
    Husson O; Nieuwlaat WA; Oranje WA; Haak HR; van de Poll-Franse LV; Mols F
    Thyroid; 2013 Oct; 23(10):1247-55. PubMed ID: 23578315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing.
    Zhi WI; Chen P; Kwon A; Chen C; Harte SE; Piulson L; Li S; Patil S; Mao JJ; Bao T
    Breast Cancer Res Treat; 2019 Dec; 178(3):587-595. PubMed ID: 31456070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.
    Knoerl R; Gray E; Stricker C; Mitchell SA; Kippe K; Smith G; Dudley WN; Lavoie Smith EM
    Support Care Cancer; 2017 Nov; 25(11):3437-3446. PubMed ID: 28577231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
    Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
    Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer.
    Tanay MA; Armes J
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13011. PubMed ID: 30790382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer-related fatigue among long-term survivors of breast, cervical, and colorectal cancer: a French registry-based controlled study.
    Gernier F; Joly F; Klein D; Mercier M; Velten M; Licaj I
    Support Care Cancer; 2020 Dec; 28(12):5839-5849. PubMed ID: 32253602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review.
    Schwab L; Visovsky C
    Front Oncol; 2022; 12():1005083. PubMed ID: 36703798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low subjective health literacy is associated with adverse health behaviors and worse health-related quality of life among colorectal cancer survivors: results from the profiles registry.
    Husson O; Mols F; Fransen MP; van de Poll-Franse LV; Ezendam NP
    Psychooncology; 2015 Apr; 24(4):478-86. PubMed ID: 25241852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.